FDB Expands AI-Driven Medication Workflow Automation with New MCP Server and Agent Solutions — First Databank, Inc.

Event summary

FDB's Model Context Protocol (MCP) server, now named FDB MedProof MCP™, has seen growing pilot adoption since its October 2025 launch.
FDB introduced two new AI-driven solutions: FDB Script Agent™ for ambulatory prescription automation and FDB VerifyAssist™ for inpatient pharmacy order verification.
Artera, a patient communications leader, is leveraging FDB MedProof MCP for AI agent integrations to enhance patient communications.
FDB Script Agent aims to reduce documentation time by 70% in ambulatory settings, while VerifyAssist targets a 30-40% reduction in pharmacist verification time.

The big picture

FDB's advancements reflect the broader industry trend of integrating AI into healthcare workflows to improve efficiency and patient safety. The company's focus on trusted medication intelligence positions it as a leader in the evolving landscape of clinical decision support. The success of these solutions will depend on their ability to balance automation with the stringent safety requirements of healthcare environments.

What we're watching

Adoption Pace: The pace at which healthcare organizations adopt FDB's new AI-driven solutions will indicate the market's readiness for advanced medication workflow automation.
Competitive Response: How competitors respond to FDB's advancements in AI-native medication intelligence solutions could shape the future landscape of healthcare workflow automation.
Regulatory Compliance: Whether FDB's solutions can maintain regulatory compliance while streamlining medication workflows will be critical for widespread adoption.